Evidence map›Paper›PMID 26132717›Full record

ArticleJournal of sex research

Influence of Partner Type on Acceptability and Likelihood of Use of a Rectal Microbicide Among Young Men Who Have Sex With Men in the United States and Puerto Rico.

Rebecca Giguere, Curtis Dolezal, José A Bauermeister, Timothy Frasca, Juan Valladares, Irma Febo, Ross D Cranston, Kenneth Mayer, Ian McGowan, Alex Carballo-Diéguez

Abstract read
In one paragraph

Article in Journal of sex research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Acceptability of PC-1005 Gel Administered Rectally to HIV-1 Seronegative Adults at Three Different Volume Levels (MTN-037).AIDS education and prevention : official publication of the International Society for AIDS Education · 2022
    Article
  7. Article
  8. Article
  9. Acceptability of a Dapivirine Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-033 Study).AIDS education and prevention : official publication of the International Society for AIDS Education · 2021
    Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Rebecca Giguerea Columbia University and NY State Psychiatric Institute, HIV Center for Clinical and Behavioral Studies.
Curtis Dolezala Columbia University and NY State Psychiatric Institute, HIV Center for Clinical and Behavioral Studies.
José A Bauermeisterb University of Michigan School of Public Health, Center for Sexuality and Health Disparities.
Timothy Frascaa Columbia University and NY State Psychiatric Institute, HIV Center for Clinical and Behavioral Studies.
Juan Valladaresa Columbia University and NY State Psychiatric Institute, HIV Center for Clinical and Behavioral Studies.
Irma Feboc Department of Pediatrics, Gama Project , University of Puerto Rico Medical Sciences Campus.
Ross D Cranstond Department of Medicine , University of Pittsburgh.
Kenneth Mayere Fenway Institute, Fenway Health.
Ian McGowanf Division of Gastroenterology, Hepatology, and Nutrition , University of Pittsburgh School of Medicine.
Alex Carballo-Diégueza Columbia University and NY State Psychiatric Institute, HIV Center for Clinical and Behavioral Studies.

Funding

University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
The Statistics, Data Science, and Data Management (SDM) CoreP30MH043520 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI Claude Ann Mellins · 2003 to 2026
$48.2M
University of Puerto Rico Clinical Trials UnitUM1AI069415 · NIAID · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI FEBO, IRMA LUZ, SANTANA-BAGUR, JORGE L. · 2012 to 2021
$15.2M
Microbicide Safety and Acceptability in Young MenR01HD059533 · NICHD · MAGEE-WOMEN'S RES INST AND FOUNDATION · PI MCGOWAN, IAN MICHAEL · 2009 to 2012
$6.6M
NCATS NIH HHS UL1 TR000005NIAID NIH HHS UM1 AI069415NICHD NIH HHS R01 HD059533NIMH NIH HHS P30 MH043520
6 · The paper itself

Abstract

This study examined how acceptability of placebo gel with receptive anal intercourse (RAI) and likelihood of future rectal microbicide use varied across partner types. Because no rectal microbicide is available yet, use of placebo permitted the study of gel use behavior in real-life circumstances. A total of 87 men who have sex with men (MSM) aged 18 to 30 years inserted placebo gel rectally before RAI during 12 weeks. Using mixed-methods design, participants completed a behavioral questionnaire and in-depth interview. In all, 62 men (71.3%) reported gel use with a lover (i.e., spouse equivalent, boyfriend), 32 (36.8%) with a one-night stand (i.e., man with whom you had sex once), and 29 (33.3%) with an "other" male partner. While gel acceptability was high across partner types, use with lovers was facilitated by trust and familiarity; yet trust made participants believe protection was less necessary. Conversely, participants expressed high likelihood of using gel with one-night stands, whom they perceived as riskier; yet they felt less comfortable discussing gel with them, often resorting to covert use or forgoing gel. A successful microbicide will be positioned as a sexual pleasure enhancer so that men can present it to their lovers and other partners as a gel that improves sex and secondarily prevents human immunodeficiency virus (HIV).

Indexed as

AdultAnti-Infective AgentsGelsHomosexuality, MaleHumansMalePatient Acceptance of Health CarePlacebosPuerto RicoSexual BehaviorSexually Transmitted DiseasesUnited StatesYoung AdultAnti-Infective AgentsGelsPlacebos

Identifiers

PMID26132717
PMCPMC4698091

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.